10,045
Total Claims
$1.5M
Drug Cost
1,201
Beneficiaries
$1,252
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
+19%
Cost per patient vs peers
$1,252 vs $1,054 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,639 claims · $186K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 520 | $586K |
| Empagliflozin | 200 | $233K |
| Sacubitril/Valsartan | 180 | $215K |
| Evolocumab | 152 | $99K |
| Rivaroxaban | 41 | $60K |
| Ticagrelor | 42 | $47K |
| Alirocumab | 53 | $35K |
| Metoprolol Succinate | 1,273 | $23K |
| Ezetimibe | 380 | $17K |
| Atorvastatin Calcium | 903 | $14K |
| Clopidogrel Bisulfate | 656 | $12K |
| Icosapent Ethyl | 16 | $12K |
| Rosuvastatin Calcium | 398 | $9,181 |
| Ranolazine | 49 | $8,429 |
| Omega-3 Acid Ethyl Esters | 47 | $8,270 |
Prescribing Profile
52
Unique Drugs
$1.1M
Patient Profile
74
Avg Age
42%
Female
1.62
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About